Russell Wallis

Simultaneous activation of complement and coagulation by MBL-associated serine protease 2

The complement system is an important immune mechanism mediating both recognition and elimination of foreign bodies. The lectin pathway is one pathway of three by which the complement system is activated. The characteristic protease of this pathway is Mannan-binding lectin (MBL)-associated serine protease 2 (MASP2), which cleaves complement proteins C2 and C4. We present a novel and alternative role of MASP2 in the innate immune system. We have shown that MASP2 is capable of promoting fibrinogen turnover by cleavage of prothrombin, generating thrombin. By using a truncated active form of MASP2 as well as full-length MASP2 in complex with MBL, we have shown that the thrombin generated is active and can cleave both factor XIII and fibrinogen, forming cross-linked fibrin. To explore the biological significance of these findings we showed that fibrin was covalently bound on a bacterial surface to which MBL/MASP2 complexes were bound. These findings suggest that, as has been proposed for invertebrates, limited clotting may contribute to the innate immune response.

The Hemopexin and O-Glycosylated Domains Tune Gelatinase B/MMP-9 Bioavailability via Inhibition and Binding to Cargo Receptors

Gelatinase B/matrix metalloproteinase-9 (MMP-9), a key regulator and effector of immunity, contains a C-terminal hemopexin domain preceded by a unique linker sequence of ∼64 amino acid residues. This linker sequence is demonstrated to be an extensively O-glycosylated (OG) domain with a compact three-dimensional structure. The OG and hemopexin domains have no influence on the cleavage efficiency of MMP-9 substrates. In contrast, the hemopexin domain contains a binding site for the cargo receptor low density lipoprotein receptor-related protein-1 (LRP-1). Furthermore, megalin/LRP-2 is identified as a new functional receptor for the hemopexin domain of MMP-9, able to mediate the endocytosis and catabolism of the enzyme. The OG domain is required to correctly orient the hemopexin domain for inhibition by TIMP-1 and internalization by LRP-1 and megalin. Therefore, the OG and hemopexin domains down-regulate the bioavailability of active MMP-9 and the interactions with the cargo receptors are proposed to be the original function of hemopexin domains in MMPs.

Sequence-controlled multi-block glycopolymers to inhibit DC-SIGN-gp120 binding.

Glycan–protein interactions are essential for many physiological processes including cell–cell recognition, cell adhesion, cell signalling, pathogen identification, and differentiation. Dendritic cell-specific intercellular adhesion molecule3-grabbing non-integrin (DC-SIGN; CD209) is a C-type lectin (carbohydrate-binding protein) present on both macrophages and dendritic cell subpopulations and plays a critical role in many cell interactions. DC-SIGN binds to microorganisms and host molecules by recognizing surface-rich mannose-containing glycans through multivalent glycan– protein interactions and serves as a target for several viruses, such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Carbohydrate-binding proteins (CBP) have been suggested as potential microbicides for the prevention of HIV infection. However, the isolation of natural CBPs is relatively difficult because of their hydrophilic nature and low affinity for the virus. 4] Thus, synthetic lectins are of interest for carbohydrate recognition studies. Alternatively, noncarbohydrate inhibitors of mammalian lectins can be used to prevent the interaction between DC-SIGN and gp120. The structures of these multivalent ligands have a great effect on carbohydrate binding to lectins, and the use of linear polymers to effectively inhibit lectin binding has been demonstrated by several research groups. Synthetic polymer chemistry has developed rapidly in recent years. Currently, polymerization of functional monomers with the desired chain length, structure, and composition is straightforward; whereas producing polymers with monomer sequence control remains challenging, which has implications for the controlled folding of synthetic macromolecules. There are a few recent reports where sufficient control has been achieved in controlling the monomer sequence along the polymer chain. To the best of our knowledge, this is the first report where some control over the relative position of the sugars is exhibited and their binding to the human lectin DC-SIGN is demonstrated. We have used a controlled polymerization technique, single-electron transfer living radical polymerization (SET-LRP), to polymerize glycomonomers, which are prepared by copper catalyzed azide–alkyne click (CuAAC) reaction prior to polymerization. A series of glycomonomers were prepared by reaction of 3-azidopropylacrylate (APA) and alkylated mannose, glucose, and fucose using a Fischer–Helferich glycosylation. This was performed using CuSO4 and sodium ascorbate in a methanol/water mixture (see the Supporting Information). SET-LRP of the glucose monomer (GluA) was performed in dimethylsulfoxide (DMSO) using a copper(0)/copper(II) and tris[2-(dimethylamino)ethyl]amine (Me6TREN)-derived catalyst. Polymerization reached over 90 % monomer conversion in six hours whilst maintaining a narrow molecular weight distribution with increasing molecular weight. (Supporting Information, Figure S4). The obtained polymers were characterized by size exclusion chromatography (SEC) and MALDI-TOF mass spectroscopy (MS) or high-resolution electrospray ionization mass spectroscopy (HR-ESI MS), which indicated very high chain-end fidelity allowing for sequential monomer addition. We designed a polymerization reaction starting with one equivalent of initiator (I) and two equivalents of mannose glycomonomer (ManA; Figure 1a). ManA was fully consumed after 12 hours; then two equivalents of GluA in DMSO were added to the reaction mixture and GluA was consumed in 16 hours. Two equivalents of ManA in DMSO were subsequently added to the reaction mixture, and this cycle was continued until six short blocks of glycopolymers were produced (the degree of polymerization (DP) = 2 for each block, (mannose)2-(glucose)2-(mannose)2-(glucose)2(mannose)2-(glucose)2). No purification steps were required prior to addition of the subsequent monomer. The conversion of the first four blocks, as analyzed by H NMR spectroscopy, reached 100 %, shown by the complete disappearance of vinyl groups at 5.7–6.5 ppm. The glycomonomers were dissolved in purged DMSO prior to their addition and this resulted in further dilution of the reaction mixture upon each monomer addition. Traces of vinyl groups could still be detected after [*] Q. Zhang, J. Collins, A. Anastasaki, Dr. C. R. Becer, Prof. D. M. Haddleton Department of Chemistry, University of Warwick Gibbet Hill Road, Coventry, CV4 7AL (UK) E-mail: d.m.haddleton@warwick.ac.uk Homepage: http://www.warwick.ac.uk/go/polymers Dr. R. Wallis Department of Biochemistry, University of Leicester Leicester, LE1 9HN (UK) Dr. D. A. Mitchell Clinical Sciences Research Institute, Warwick Medical School, University of Warwick Coventry, CV2 2DX (UK) [**] We acknowledge financial support from the University of Warwick and the China Scholarship Council. Equipment used in this research was funded by the Innovative Uses for Advanced Materials in the Modern World (AM2) with support from AWM and ERDF. D.M.H. is a Royal Society/Wolfson Fellow and C.R.B. is a Science City Senior Research Fellow. Dr. Christopher N. Scanlan has provided the gp120. Supporting information for this article (syntheses of all materials and details of the characterization methods) is available on the WWW under http://dx.doi.org/10.1002/anie.201300068. Angewandte Chemie

Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury

Complement research experienced a renaissance with the discovery of a third activation route, the lectin pathway. We developed a unique model of total lectin pathway deficiency, a mouse strain lacking mannan-binding lectin-associated serine protease-2 (MASP-2), and analyzed the role of MASP-2 in two models of postischemic reperfusion injury (IRI). In a model of transient myocardial IRI, MASP-2–deficient mice had significantly smaller infarct volumes than their wild-type littermates. Mice deficient in the downstream complement component C4 were not protected, suggesting the existence of a previously undescribed lectin pathway-dependent C4-bypass. Lectin pathway-mediated activation of C3 in the absence of C4 was demonstrated in vitro and shown to require MASP-2, C2, and MASP-1/3. MASP-2 deficiency also protects mice from gastrointestinal IRI, as do mAb-based inhibitors of MASP-2. The therapeutic effects of MASP-2 inhibition in this experimental model suggest the utility of anti–MASP-2 antibody therapy in reperfusion injury and other lectin pathway-mediated disorders.

High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein

Noncovalent interactions between complex carbohydrates and proteins drive many fundamental processes within biological systems, including human immunity. In this report we aimed to investigate the potential of mannose-containing glycopolymers to interact with human DC-SIGN and the ability of these glycopolymers to inhibit the interactions between DC-SIGN and the HIV envelope glycoprotein gp120. We used a library of glycopolymers that are prepared via combination of copper-mediated living radical polymerization and azide−alkyne [3+2] Huisgen cycloaddition reaction. We demonstrate that a relatively simple glycopolymer can effectively prevent the interactions between a human dendritic cell associated lectin (DC-SIGN) and the viral envelope glycoprotein gp120. This approach may give rise to novel insights into the mechanisms of HIV infection and provide potential new therapeutics.

Paths reunited: Initiation of the classical and lectin pathways of complement activation.

Understanding the structural organisation and mode of action of the initiating complex of the classical pathway of complement activation (C1) has been a central goal in complement biology since its isolation almost 50 years ago. Nevertheless, knowledge is still incomplete, especially with regard to the interactions between its subcomponents C1q, C1r and C1s that trigger activation upon binding to a microbial target. Recent studies have provided new insights into these interactions, and have revealed unexpected parallels with initiating complexes of the lectin pathway of complement: MBL-MASP and ficolin-MASP. Here, we develop and expand these concepts and delineate their implications towards the key aspects of complement activation via the classical and lectin pathways.

Two Mechanisms for Mannose-binding Protein Modulation of the Activity of Its Associated Serine Proteases

Serum mannose-binding protein (MBP) neutralizes invading microorganisms by binding to cell surface carbohydrates and activating MBP-associated serine proteases-1, -2, and -3 (MASPs). MASP-2 subsequently cleaves complement components C2 and C4 to activate the complement cascade. To analyze the mechanisms of activation and substrate recognition by MASP-2, zymogen and activated forms have been produced, and MBP·MASP-2 complexes have been created. These preparations have been used to show that MBP modulates MASP-2 activity in two ways. First, MBP stimulates MASP-2 autoactivation by increasing the rate of autocatalysis when MBP·MASP-2 complexes bind to a glycan-coated surface. Second, MBP occludes accessory C4-binding sites on MASP-2 until activation occurs. Once these sites become exposed, MASP-2 binds to C4 while separate structural changes create a functional catalytic site able to cleave C4. Only activated MASP-2 binds to C2, suggesting that this substrate interacts only near the catalytic site and not at accessory sites. MASP-1 cleaves C2 almost as efficiently as MASP-2 does, but it does not cleave C4. Thus MASP-1 probably enhances complement activation triggered by MBP·MASP-2 complexes, but it cannot initiate activation itself.

Molecular Determinants of Oligomer Formation and Complement Fixation in Mannose-binding Proteins

Rat serum mannose-binding protein (MBP-A) functions as part of the innate immune system by targetting complement toward potentially pathogenic microorganisms. In order to examine the molecular basis for complement activation, rat MBP-A has been overproduced in Chinese hamster ovary cells. Recombinant protein is post-translationally modified in the same way as the native lectin. Hydrodynamic studies indicate that MBP-A consists predominantly of covalent oligomers containing one to four copies of a subunit that comprises a trimer of polypeptides. These oligomers are non-interconverting and do not assemble into higher order structures at concentrations in excess of those normally found in serum. Disulfide bonds formed between cysteine residues at the N-terminal end of the collagen-like domain link polypeptides to form covalent oligomers. Analysis of wild-type MBP-A and MBP-A containing the substitution Cys6 → Ser suggests that polypeptides within each trimeric structural unit are mostly linked by disulfide bonds between cysteine residues at positions 13 and 18 arranged in an asymmetrical configuration. Disulfide bonds involving Cys6 connect polypeptides within separate trimers. Analysis of chimeras between MBP-A and rat liver MBP (MBP-C) indicates that residues within the N-terminal region of the collagenous domain and the cysteine-rich domain of MBP-A enable assembly of trimers into higher order oligomers. The activity of MBP-A in a hemolytic complement fixation assay using mannan-coated sheep erythrocytes was approximately 20-fold greater than the activity of MBP-C. Analysis of the MBP chimeras and isolated oligomers of MBP-A reveals that the larger oligomers are more efficient at complement activation. These data indicate that the overall complement fixing activity of MBP-A is a function of the individual molecular activities of oligomers and their relative abundance within the serum.

Crystal structure of the CUB1‐EGF‐CUB2 region of mannose‐binding protein associated serine protease‐2

Serum mannose‐binding proteins (MBPs) are C‐type lectins that recognize cell surface carbohydrate structures on pathogens, and trigger killing of these targets by activating the complement pathway. MBPs circulate as a complex with MBP‐associated serine proteases (MASPs), which become activated upon engagement of a target cell surface. The minimal functional unit for complement activation is a MASP homodimer bound to two MBP trimeric subunits. MASPs have a modular structure consisting of an N‐terminal CUB domain, a Ca2+‐binding EGF‐like domain, a second CUB domain, two complement control protein modules and a C‐terminal serine protease domain. The CUB1‐EGF‐CUB2 region mediates homodimerization and binding to MBP. The crystal structure of the MASP‐2 CUB1‐EGF‐CUB2 dimer reveals an elongated structure with a prominent concave surface that is proposed to be the MBP‐binding site. A model of the full six‐domain structure and its interaction with MBPs suggests mechanisms by which binding to a target cell transmits conformational changes from MBP to MASP that allow activation of its protease activity.

Interaction of Mannose-binding Protein with Associated Serine Proteases EFFECTS OF NATURALLY OCCURRING MUTATIONS

Mannose-binding protein (MBP; mannose-binding lectin) forms part of the innate immune system. By binding directly to carbohydrates on the surfaces of potential microbial pathogens, MBP and MBP-associated serine proteases (MASPs) can replace antibodies and complement components C1q, C1r, and C1s of the classical complement pathway. In order to investigate the mechanisms of MASP activation by MBP, the cDNAs of rat MASP-1 and -2 have been isolated, and portions encompassing the N-terminal CUB and epidermal growth factor-like domains have been expressed and purified. Biophysical characterization of the purified proteins indicates that each truncated MASP is a Ca2+-independent homodimer in solution, in which the interacting modules include the N-terminal two domains. Binding studies reveal that both MASPs associate independently with rat MBP in a Ca2+-dependent manner through interactions involving the N-terminal three domains. The biophysical properties of the truncated MASPs indicate that the interactions with MBP leading to complement activation differ significantly from those between components C1q, C1r, and C1s of the classical pathway. Analysis of MASP binding by rat MBP containing naturally occurring mutations equivalent to those associated with human immunodeficiency indicates that binding to both truncated MASP-1 and MASP-2 proteins is defective in such mutants.